JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258733

Human TP53INP2 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TP53INP2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon4.

View Alternative Names

C20orf110, DOR, Diabetes and obesity regulated; p53 inducible protein U, PINH, T53I2_HUMAN, Tumor protein p53-inducible nuclear protein 2, p53-inducible protein U

1 Images
Sanger Sequencing - Human TP53INP2 knockout HEK-293T cell lysate (AB258733)
  • Sanger seq

Unknown

Sanger Sequencing - Human TP53INP2 knockout HEK-293T cell lysate (AB258733)

Homozygous : 1 bp insertion in exon4

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon4.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258733-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TP53INP2 knockout HEK293T cell lysate", "number":"AB258733-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258733-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
TP53INP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TP53INP2 also known as p53-inducible nuclear protein 2 is a 104 amino acids protein with a molecular weight of approximately 12 kDa. This protein actively engages in the regulation of autophagy and transcription processes. It is mainly expressed in human tissues like the brain liver heart and pancreas. In cellular environments TP53INP2 moves between the nucleus and the cytoplasm which suggests it plays a dynamic role in cellular homeostasis by potentially interacting with different cellular structures.
Biological function summary

TP53INP2 plays a significant role in modulating the cellular stress response and apoptosis. It interacts with autophagy-related proteins to facilitate the degradation of damaged cellular components. TP53INP2 is not generally described as part of a larger protein complex but its interactions with several autophagy-related proteins underline its involvement in cellular cleaning and recycling systems aiding in the balance between cell survival and cell death.

Pathways

TP53INP2 connects to both the autophagy and apoptosis pathways. Within the autophagy pathway TP53INP2 collaborates with proteins like LC3 and Beclin-1 to promote the formation of autophagosomes. Meanwhile in apoptosis pathways TP53INP2 affects the activity of the tumor suppressor protein p53 providing a link between autophagic processes and programmed cell death especially under cellular stress conditions.

TP53INP2 correlates with cancer and neurodegenerative diseases. In cancer the interaction with p53 signifies a role in tumorigenesis where altered TP53INP2 expression might contribute to cancer progression. In neurodegenerative disorders such as Alzheimer’s disease the role of TP53INP2 in autophagy becomes essential as impaired autophagy is often linked with such diseases. The protein’s connections to key mechanisms suggest its potential as a therapeutic target in diseases where autophagy and cell death processes are disrupted.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com